生物聚合物用于先天性心脏病外科:体外耐久性测试
本研究通过改变培养基组成和延长培养时间两种修饰条件,提升细菌纤维素(BC)的生物力学性能。修饰后BC补片在1000 mmHg以上压力下耐久性达100%(n=24),最大拉伸强度从0.311±0.057 MPa提升至0.986±0.397 MPa(P<.0001),长期疲劳测试中承受相当于6个月循环无失败,显示其用于先天性心脏病外科的潜力。
要点
- 修饰培养条件可显著提升BC补片的拉伸强度与耐压性能。
- 修饰后BC补片在1000 mmHg以上压力下耐久性为100%(n=24)。
- 长期疲劳测试中BC补片承受相当于6个月循环无失败。
核心结论
- 通过培养修饰增强细菌纤维素的生物力学性能,展示了其用于先天性心脏病外科的潜力,值得进一步研究开发。
研究设计与样本
- 体外实验研究:按标准方案生产细菌纤维素,采用充气压力测试、厚度测量和单轴拉伸测试评估生物力学性能。
- 实施两种修饰(改变生长培养基组成和延长孵育时间),并在5个后续测试系列中评估。
- 使用疲劳测试仪对BC补片进行20±0.5百万次循环的长期耐久性评估,并用扫描电子显微镜检查潜在结构损伤。
主要发现
- 修饰后BC补片在超过1000 mmHg压力下耐久性为100%(n=24),而标准BC在500 mmHg下耐久性为20.8%(n=24)。
- 最大拉伸强度从0.311±0.057 MPa提升至0.986±0.397 MPa(P<.0001),厚度为3.89±0.95 mm(P<.0001)。
- 长期耐久性测试中,补片承受相当于6个月的持续时间无失败,并保持结构完整性。
临床怎么用
- BC经培养修饰后生物力学性能提升,可作为先天性心脏病外科材料的候选,但需进一步体内研究和开发。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Currently available materials in congenital cardiac surgery (CCS) are far from optimal because they do not facilitate growth, remodelling, or renewal, resulting in poorer long-term outcomes due to material-related limitations. Bacterial cellulose (BC), a biogenic polymer-based material produced by Acetobacter xylinum, has emerged as a promising alternative exhibiting excellent bio- and haemocompatibility. This study aimed to develop BC specifically for application in CCS by modifying culturing conditions to enhance its biomechanical resilience. METHODS: Bacterial cellulose was produced according to a standard protocol, and its biomechanical properties were evaluated using inflation pressure testing, thickness measurement, and uniaxial tensile testing. To improve these characteristics, 2 modifications, a change in the growth media composition and an extended incubation time, were implemented and subsequently evaluated in 5 further test series. The long-term durability of BC patches was assessed in a fatigue tester for 20 ± 0.5 million cycles, and potential structural damage was investigated using scanning electron microscopy. RESULTS: Utilizing the 2 modifications, BC patches demonstrated a capability to reach and maintain pressures exceeding 1000 mm Hg with a durability of 100% (n = 24), compared to the standard 20.8% (n = 24) at 500 mm Hg. The maximum tensile strength was enhanced from 0.311 ± 0.057 megapascal (MPa) to 0.986 ± 0.397 MPa (P < .0001), with a thickness of 3.89 ± 0.95 mm (P < .0001). In the long-term durability testing, patches endured durations equalling 6 months without failure while retaining structural integrity. CONCLUSIONS: The potential of BC for use in CCS was demonstrated by enhancing its biomechanical properties through culturing modifications, warranting further investigation and development of the biomaterial.
引用
- Hubrich J, Grefen L, Zorin A, et al. Biogenic Polymers for Congenital Cardiac Surgery: In Vitro Durability Testing. Eur J Cardiothorac Surg. 2025. PMID: 40986395. doi:10.1093/ejcts/ezaf310
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。